TRYP — Tryp Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$5.79m
- CA$8.73m
Annual balance sheet for Tryp Therapeutics, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 1.02 | 3.69 | 1.81 | 0.359 |
| Net Total Receivables | — | 0.022 | 0.006 | 0.029 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1.05 | 4.08 | 2.18 | 0.482 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 2.04 | 4.11 | 2.34 | 0.653 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.193 | 0.185 | 1.2 | 1.97 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.193 | 0.185 | 1.2 | 4.41 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 1.84 | 3.92 | 1.14 | -3.76 |
| Total Liabilities & Shareholders' Equity | 2.04 | 4.11 | 2.34 | 0.653 |
| Total Common Shares Outstanding |